Obinutuzumab in Refractory Membranous Nephropathy: A Case Series

Rationale & Objective: Membranous nephropathy (MN), recognized as an autoimmune kidney disease, responds well to anti-CD20 monoclonal antibodies. Obinutuzumab, a type Ⅱ humanized anti-CD20 and immunoglobulin G1 Fc-optimized monoclonal antibody, when compared with rituximab, has demonstrated supe...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Yuxin Lin, Quan Han, Liangliang Chen, Yaomin Wang, Pingping Ren, Guangjun Liu, Lan Lan, Xin Lei, Jianghua Chen, Fei Han
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2024-08-01
Cyfres:	Kidney Medicine
Pynciau:	Obinutuzumab membranous nephropathy rituximab remission
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2590059524000645
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!